BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32564169)

  • 1. Update on Pediatric Brain Tumors: the Molecular Era and Neuro-immunologic Beginnings.
    Duke ES; Packer RJ
    Curr Neurol Neurosci Rep; 2020 Jun; 20(8):30. PubMed ID: 32564169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is New in Neuro-oncology?
    Thakkar JP; Prabhu VC; Peters KB; Lukas RV
    Neurol Clin; 2021 Feb; 39(1):163-179. PubMed ID: 33223081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Neurological Complications of Brain Tumors and Immune Therapies, a Guideline for the Neuro-hospitalist.
    Thakkar JP; Prabhu VC; Rouse S; Lukas RV
    Curr Neurol Neurosci Rep; 2020 Jun; 20(8):32. PubMed ID: 32596758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community.
    Aldape K; Nejad R; Louis DN; Zadeh G
    Neuro Oncol; 2017 Mar; 19(3):336-344. PubMed ID: 27688263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foundations of Neuro-Oncology: A Multidisciplinary Approach.
    Barbaro M; Fine HA; Magge RS
    World Neurosurg; 2021 Jul; 151():392-401. PubMed ID: 33618043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
    Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG
    J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case Series.
    Bächli H; Ecker J; van Tilburg C; Sturm D; Selt F; Sahm F; Koelsche C; Grund K; Sutter C; Pietsch T; Witt H; Herold-Mende C; von Deimling A; Jones D; Pfister S; Witt O; Milde T
    Klin Padiatr; 2018 Oct; 230(6):305-313. PubMed ID: 29996150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.
    Glod J; Rahme GJ; Kaur H; H Raabe E; Hwang EI; Israel MA
    J Pediatr Hematol Oncol; 2016 May; 38(4):249-60. PubMed ID: 26989915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current WHO Guidelines and the Critical Role of Genetic Parameters in the Classification of Glioma: Opportunities for Immunotherapy.
    Yuan F; Wang Y; Ma C
    Curr Treat Options Oncol; 2022 Feb; 23(2):188-198. PubMed ID: 35182297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of molecular classification and treatment implications of pediatric brain tumors.
    Guerreiro Stucklin AS; Ramaswamy V; Daniels C; Taylor MD
    Curr Opin Pediatr; 2018 Feb; 30(1):3-9. PubMed ID: 29315108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Neuro-oncology.
    Malbari F
    Continuum (Minneap Minn); 2023 Dec; 29(6):1680-1709. PubMed ID: 38085894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The landscape of neuro-oncology in East Africa: a review of published records.
    Haizel-Cobbina J; Chen JW; Belete A; Dewan MC; Karekezi C
    Childs Nerv Syst; 2021 Oct; 37(10):2983-2992. PubMed ID: 34468839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
    Robinson GW; Witt H; Resnick A
    Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Radiation Therapy in Pediatric Neuro-oncology.
    Bindra RS; Wolden SL
    J Child Neurol; 2016 Mar; 31(4):506-16. PubMed ID: 26271789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of Genomic Sequencing in Pediatric CNS Tumors.
    Bavle AA; Lin FY; Parsons DW
    Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Diagnostic and Therapeutic Outcomes in Pediatric Brain Tumors.
    Grob ST; Levy JMM
    Mol Diagn Ther; 2018 Feb; 22(1):25-39. PubMed ID: 28900876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
    Fuller CE; Jones DTW; Kieran MW
    Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice.
    Galanis E; Nassiri F; Coy S; Nejad R; Zadeh G; Santagata S
    Am Soc Clin Oncol Educ Book; 2018 May; 38():148-157. PubMed ID: 30231374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Advances and Targeted Therapies for Pediatric Central Nervous System Tumors.
    Gordon D; Maria BL
    J Child Neurol; 2021 Jan; 36(1):5-29. PubMed ID: 32807014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology.
    Foster JB; Alonso MM; Sayour E; Davidson TB; Persson ML; Dun MD; Kline C; Mueller S; Vitanza NA; van der Lugt J
    Neoplasia; 2023 Aug; 42():100909. PubMed ID: 37244226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.